Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Astrazeneca Plc ADR
(NQ:
AZN
)
81.65
+1.03 (+1.28%)
Streaming Delayed Price
Updated: 1:59 PM EDT, Aug 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,317,642
Open
80.35
Bid (Size)
81.64 (10)
Ask (Size)
81.65 (7)
Prev. Close
80.62
Today's Range
80.13 - 81.66
52wk Range
60.47 - 82.01
Shares Outstanding
N/A
Dividend Yield
1.14%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
EXCLUSIVE: Penny Stock Conduit Pharmaceuticals Inks Licensing Pact With AstraZeneca For Multiple Assets
Today 6:00 EDT
Conduit Pharmaceuticals has entered an exclusive licensing agreement with AstraZeneca to develop AZD1656, AZD5658, and AZD5904, targeting autoimmune disorders and idiopathic male infertility. Conduit...
Via
Benzinga
Top Analyst Reports For AstraZeneca, TotalEnergies & ConocoPhillips
August 07, 2024
Today's Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC, TotalEnergies SE and ConocoPhillips.
Via
Talk Markets
Performance
YTD
+19.37%
+19.37%
1 Month
+5.86%
+5.86%
3 Month
+6.08%
+6.08%
6 Month
+22.69%
+22.69%
1 Year
+15.85%
+15.85%
More News
Read More
Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data
August 05, 2024
Via
Benzinga
Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market
August 04, 2024
Via
The Motley Fool
Bank Of England Reduces 16-Year High Interest Rates In Divided Decision As Inflation Hits 2%
August 01, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Kazia Therapeutics Stock: Is KZIA a Buyout Candidate in the Making?
July 31, 2024
Via
InvestorPlace
Bristol Myers, Johnson & Johnson, AbbVie, AstraZeneca Expect Minimal Impact From Upcoming Medicare Price Negotiations
July 30, 2024
Via
Benzinga
Fixed-duration CALQUENCE® (acalabrutinib) plus venetoclax, with or without obinutuzumab, significantly improved progression-free survival in 1st-line chronic lymphocytic leukemia in AMPLIFY Phase III trial
July 29, 2024
From
AstraZeneca
Via
Business Wire
UK Agency Says AstraZeneca's Breast Cancer Drug Enhertu Is Expensive, CEO Pascal Soriot Urges Review Of Drug Pricing Assessment
July 26, 2024
Via
Benzinga
3 Surprisingly Underrated Stocks to Buy Right Now
July 26, 2024
Via
The Motley Fool
AstraZeneca Shares Fall Despite EPS Beat and Raised Guidance
July 26, 2024
Via
MarketBeat
Topics
ETFs
7 Explosive Growth Stocks Set to Soar in 2024
July 25, 2024
Via
InvestorPlace
Why AstraZeneca Stock Is Sliding Today
July 25, 2024
Via
The Motley Fool
AstraZeneca Plc (AZN) Q2 2024 Earnings Call Transcript
July 25, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Stocks Rebound As US Economy Flexes Muscles, Small Caps Rally, Gold Falls: What's Driving Markets Thursday?
July 25, 2024
Via
Benzinga
Topics
Economy
Exposures
Economy
AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its Outlook
July 25, 2024
Via
Investor's Business Daily
AstraZeneca Posts Mixed Q2 Earnings, Still Raises Annual Guidance On Strong Demand For Cancer, Rare Disease Medicines
July 25, 2024
Via
Benzinga
Sanofi Raises 2024 Profit Outlook On Strong Q2 Earnings, Blockbuster Drug Dupixent Sees Strong Demand
July 25, 2024
Via
Benzinga
Nasdaq, S&P Futures Slide On More Negative Tech Tidings As Focus Shifts To Q2 GDP Data: Strategist Says Trump Trades May Not Work Even If Ex-President Retakes White House
July 25, 2024
Via
Benzinga
Topics
Government
Stocks
Exposures
Political
US Equities
AstraZeneca’s H1 and Q2 2024 Financial Results
July 25, 2024
From
AstraZeneca
Via
Business Wire
AZN Stock Earnings: AstraZeneca Misses EPS, Beats Revenue for Q2 2024
July 25, 2024
Via
InvestorPlace
Morgan Stanley Predicts Triple-Digit Rally for These 3 Stocks
July 25, 2024
Via
InvestorPlace
American Airlines, AstraZeneca And 3 Stocks To Watch Heading Into Thursday
July 25, 2024
Via
Benzinga
Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage Study In Infants
July 23, 2024
Via
Benzinga
AstraZeneca, Sanofi And Other Pharma Giants Pursue Chinese Deals Despite Rising US-China Strife
July 23, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.